<DOC>
	<DOCNO>NCT01722513</DOCNO>
	<brief_summary>The aim prospective , randomize , control study investigate effect pretreatment intravenous Alprostadil incidence CIN high-risk population patient type 2 diabetes mellitus ( T2DM ) CKD undergo coronary angiography , evaluate influence potential benefit short-term outcome .</brief_summary>
	<brief_title>Efficacy Safety Alprostadil Prevent Contrast Induced Nephropathy</brief_title>
	<detailed_description>The number cardiac angiography percutaneous coronary intervention ( PCI ) increase steadily recent year . This result increase incidence contrast-induced nephropathy ( CIN ) . Major risk factor CIN include old age , diabetes mellitus ( DM ) , chronic kidney disease ( CKD ) . The aim prospective , randomize , control study investigate effect pretreatment intravenous Alprostadil incidence CIN high-risk population patient type 2 diabetes mellitus ( T2DM ) CKD undergo coronary angiography , evaluate influence potential benefit short-term outcome .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Alprostadil</mesh_term>
	<criteria>Patient underwent coronary angiography T2DM CKD stag 2 3 , eGFR 30 89ml/min per 1.73m2 Alprostadil naive , Alprostadil treatment least 14 day Withdrawal metformin aminophylline 48h angiography serum Cr . More 3 mg/dl electrolyte acidbase imbalance pulmonary edema allergy Alprostadil</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Contrast Induced Nephropathy</keyword>
</DOC>